Informações:
Falhas:
ID
44687
Descrição
The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark; ODM derived from: https://clinicaltrials.gov/show/NCT00479973
Link
https://clinicaltrials.gov/show/NCT00479973
Palavras-chave
Versões (2)
- 07/09/2017 07/09/2017 -
- 27/09/2021 27/09/2021 -
Transferido a
27 de setembro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes NCT00479973
Eligibility Type 2 Diabetes NCT00479973
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT00479973
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
diagnosed with type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Age
Item
aged > 30
boolean
C0001779 (UMLS CUI [1])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Antidiabetics Absent | Antilipemic agent Absent | Pharmacotherapy Stable | Pharmaceutical Preparations Dosage unchanged
Item
not taking anti-diabetic or lipid-lowering medication or on a stable drug regimen for at least 3 months without any planned dosage change by the participants attending physician
boolean
C0935929 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0086440 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0013216 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
C0013227 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0442739 (UMLS CUI [4,3])
C0332197 (UMLS CUI [1,2])
C0086440 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0013216 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
C0013227 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0442739 (UMLS CUI [4,3])
Fasting blood glucose measurement
Item
have fasting blood glucose at or between 8-15 mmol/l
boolean
C0428568 (UMLS CUI [1])
Absence Pharmaceutical Preparations Affecting Serum Observation parameter | Absence Natural Product Affecting Serum Observation parameter
Item
not taking any medications or natural health products that may affect serum parameters tested
boolean
C0332197 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0229671 (UMLS CUI [1,4])
C0449381 (UMLS CUI [1,5])
C0332197 (UMLS CUI [2,1])
C1512076 (UMLS CUI [2,2])
C0392760 (UMLS CUI [2,3])
C0229671 (UMLS CUI [2,4])
C0449381 (UMLS CUI [2,5])
C0013227 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0229671 (UMLS CUI [1,4])
C0449381 (UMLS CUI [1,5])
C0332197 (UMLS CUI [2,1])
C1512076 (UMLS CUI [2,2])
C0392760 (UMLS CUI [2,3])
C0229671 (UMLS CUI [2,4])
C0449381 (UMLS CUI [2,5])
Exercise education | Exercise Change Improving Glucose control | Diet education | Change in diet Improving Glucose control
Item
having already been educated in exercise and dietary changes known to improve glucose control
boolean
C0582396 (UMLS CUI [1])
C0015259 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C1272745 (UMLS CUI [2,3])
C0726398 (UMLS CUI [2,4])
C0204932 (UMLS CUI [3])
C3671772 (UMLS CUI [4,1])
C1272745 (UMLS CUI [4,2])
C0726398 (UMLS CUI [4,3])
C0015259 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C1272745 (UMLS CUI [2,3])
C0726398 (UMLS CUI [2,4])
C0204932 (UMLS CUI [3])
C3671772 (UMLS CUI [4,1])
C1272745 (UMLS CUI [4,2])
C0726398 (UMLS CUI [4,3])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetics
boolean
C0011854 (UMLS CUI [1])
Insulin
Item
patients taking insulin
boolean
C0021641 (UMLS CUI [1])
Pregnancy | Pregnancy, Planned
Item
pregnant or planned pregnancy
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0032992 (UMLS CUI [2])
Breast Feeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])
Hypersensitivity Cinnamon Ingredient
Item
known allergy to ingredients in cinnamonforce
boolean
C0020517 (UMLS CUI [1,1])
C0939899 (UMLS CUI [1,2])
C1550600 (UMLS CUI [1,3])
C0939899 (UMLS CUI [1,2])
C1550600 (UMLS CUI [1,3])
Heart Disease | Liver disease | Kidney Disease | Endocrine System Disease | Nervous system disorder
Item
patients with underlying heart, liver, kidney, endocrine or neurologic disease
boolean
C0018799 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0014130 (UMLS CUI [4])
C0027765 (UMLS CUI [5])
C0023895 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0014130 (UMLS CUI [4])
C0027765 (UMLS CUI [5])
Hypoglycemic Agents Unstable | Lipid-lowering therapy Unstable | Pharmacotherapy short-term | Pharmaceutical Preparations Affecting Serum Observation parameter
Item
patients on an unstable hypoglycemic or lipid-lowering drug regime or patients on a drug regimen for less than 3 months, and patients taking medication that may affect serum parameters tested
boolean
C0020616 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0585943 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0013216 (UMLS CUI [3,1])
C0443303 (UMLS CUI [3,2])
C0013227 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0229671 (UMLS CUI [4,3])
C0449381 (UMLS CUI [4,4])
C0443343 (UMLS CUI [1,2])
C0585943 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0013216 (UMLS CUI [3,1])
C0443303 (UMLS CUI [3,2])
C0013227 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0229671 (UMLS CUI [4,3])
C0449381 (UMLS CUI [4,4])